Annovis Bio
ANVS
57 hedge funds and large institutions have $109M invested in Annovis Bio in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 7 closing their positions.
371% more capital invested
Capital invested by funds: $23.1M → $109M (+$85.8M)
371% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 7
84% more funds holding
Funds holding: 31 → 57 (+26)
4.01% more ownership
Funds ownership: 12.01% → 16.01% (+4%)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Voloridge Investment Management
Jupiter,
Florida
|
+$4.73M |
| 2 |
BlackRock
New York
|
+$4.67M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.81M |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$1.81M |
| 5 |
Morgan Stanley
New York
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.15M |
| 2 |
Renaissance Technologies
New York
|
-$555K |
| 3 |
SIAP
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
|
-$513K |
| 4 |
LIG
Lokken Investment Group
Lewes,
Delaware
|
-$486K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$472K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Rockefeller Capital Management
New York
| $85K | – | – | – |
|
|
SWM
52
Spire Wealth Management
Mclean,
Virginia
| $65K | -$11.3K | -245 | -25% |
|
53
Wells Fargo
San Francisco,
California
| $47K | +$23.7K | +512 | +2,048% |
|
54
US Bancorp
Minneapolis,
Minnesota
| $43K | +$23.1K | +500 | New |
|
|
OSAM
55
O'Shaughnessy Asset Management
Stamford,
Connecticut
| $3K | +$1.48K | +32 | New |
|
56
Federated Hermes
Pittsburgh,
Pennsylvania
| $2K | +$878 | +19 | New |
|
|
MAM
57
McCarthy Asset Management
Redwood Shores,
California
| $1K | +$508 | +11 | New |
|
|
58
Renaissance Technologies
New York
| – | -$555K | -19,900 | Closed |
|
|
LIG
59
Lokken Investment Group
Lewes,
Delaware
| – | -$486K | -17,411 | Closed |
|
60
Citadel Advisors
Miami,
Florida
| – | -$250K | -8,963 | Closed |
|
|
TRCT
61
Tower Research Capital (TRC)
New York
| – | -$63K | -2,259 | Closed |
|
62
Citigroup
New York
| – | -$8K | -303 | Closed |
|
|
TCWM
63
Total Clarity Wealth Management
St. Charles,
Illinois
| – | -$6K | -200 | Closed |
|
ANVS Hedge Fund Activity: Q2 2021 in Review
57 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q2 2021, worth a combined $109M — up 371% from $23.1M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new ANVS positions and 7 closed out — a net gain of 26 holders — while 10 added to existing stakes and 12 trimmed.
The largest buyer was Voloridge Investment Management, opening a new position worth an estimated $4.73M. The largest seller was Ikarian Capital, cutting an estimated $4.15M.
- 57 institutional investors held Annovis Bio (ANVS) as of Q2 2021, up from 31 in Q1 2021.
- Funds reported $109M of Annovis Bio stock for Q2 2021, up 371% quarter-over-quarter.
- 33 funds opened new Annovis Bio positions in Q2 2021 and 7 closed out, a net change of +26 holders.
- The largest Annovis Bio buyer in Q2 2021 was Voloridge Investment Management, an estimated $4.73M added.
- The largest Annovis Bio seller in Q2 2021 was Ikarian Capital, an estimated $4.15M sold.
Based on aggregated 13F filings for Q2 2021.